Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial

Diabetes Care - United States
doi 10.2337/dc11-2556
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Simvastatin/Fenofibrate Combination in the Treatment of Dyslipidemia: Current Evidence

Research and Reports in Endocrine Disorders
2014English

The Influence of Weight Excess on the Postprandial Lipemia in Adolescents

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2013English

Exercise and Dietary-Mediated Reductions in Postprandial Lipemia

Journal of Nutrition and Metabolism
NutritionDieteticsFood ScienceEndocrinologyMetabolismDiabetes
2014English

The Influence of Intense Intermittent Versus Moderate Continuous Exercise on Postprandial Lipemia

Clinics
Medicine
2011English

Postprandial Lipemia as Cardiovascular Disease Risk Factor

2019English

Simvastatin Plus Fenofibrate as a Fixed Dose Combination in the Treatment of Mixed Dyslipidemia in Greece: Budget Impact Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Pleiotropic Effects of Fenofibrate Therapy on Rats With Hypertriglycemia

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2015English

Effects of a 1,3-Diacylglycerol Oil-Enriched Diet on Postprandial Lipemia in People With Insulin Resistance

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2007English

Cardiovascular and Inflammatory Effects of Simvastatin Therapy in Patients With COPD: A randomized Controlled Trial

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy